![Safety and immunogenicity of double-dose versus standard-dose hepatitis B revaccination in non-responding adults with HIV-1 (ANRS HB04 B-BOOST): a multicentre, open-label, randomised controlled trial - The Lancet Infectious Diseases Safety and immunogenicity of double-dose versus standard-dose hepatitis B revaccination in non-responding adults with HIV-1 (ANRS HB04 B-BOOST): a multicentre, open-label, randomised controlled trial - The Lancet Infectious Diseases](https://www.thelancet.com/cms/attachment/2048105639/2058221837/gr1.gif)
Safety and immunogenicity of double-dose versus standard-dose hepatitis B revaccination in non-responding adults with HIV-1 (ANRS HB04 B-BOOST): a multicentre, open-label, randomised controlled trial - The Lancet Infectious Diseases
![HIV infection and the implication for COVID‐19 vaccination - Oyelade - 2022 - Public Health Challenges - Wiley Online Library HIV infection and the implication for COVID‐19 vaccination - Oyelade - 2022 - Public Health Challenges - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/c9dc09ee-d505-4d1a-bf6a-ab080ed38376/puh214-fig-0001-m.jpg)
HIV infection and the implication for COVID‐19 vaccination - Oyelade - 2022 - Public Health Challenges - Wiley Online Library
![Scoperta una nuova variante di HIV: è più virulenta ma i farmaci rimangono efficaci | Il Bo Live UniPD Scoperta una nuova variante di HIV: è più virulenta ma i farmaci rimangono efficaci | Il Bo Live UniPD](https://ilbolive.unipd.it/sites/default/files/2019-03/n_hiv.jpg)
Scoperta una nuova variante di HIV: è più virulenta ma i farmaci rimangono efficaci | Il Bo Live UniPD
![Notes from the Field: Increase in Meningococcal Disease Among Persons with HIV — United States, 2022 | MMWR Notes from the Field: Increase in Meningococcal Disease Among Persons with HIV — United States, 2022 | MMWR](https://www.cdc.gov/mmwr/volumes/72/wr/social-media/mm7224a4_Meningococcal-disease_HIV_IMAGE_16June2023_1200x675.jpg)
Notes from the Field: Increase in Meningococcal Disease Among Persons with HIV — United States, 2022 | MMWR
![National AIDS Trust on X: "📢 Updated guidance from @BritishHIVAssoc, @THTorguk and @NAT_AIDS_Trust on third COVID vaccines and boosters for people living with #HIV. Read more here >> https://t.co/1w4jWIYvQ3 https://t.co/IiNeBRLzmy" / X National AIDS Trust on X: "📢 Updated guidance from @BritishHIVAssoc, @THTorguk and @NAT_AIDS_Trust on third COVID vaccines and boosters for people living with #HIV. Read more here >> https://t.co/1w4jWIYvQ3 https://t.co/IiNeBRLzmy" / X](https://pbs.twimg.com/media/FAD6sDJWUAEQk2G.jpg:large)